Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine-induced obsessive-compulsive symptoms (Q43497929)

24 November 2017

Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine-induced obsessive-compulsive symptoms (English)

1 reference

24 November 2017

Jun Cai

1

1 reference

24 November 2017

Wen Zhang

2

1 reference

24 November 2017

Zhenghui Yi

3

1 reference

24 November 2017

Weihong Lu

4

1 reference

24 November 2017

Zhiguo Wu

5

1 reference

24 November 2017

Jun Chen

6

1 reference

24 November 2017

Shunying Yu

7

1 reference

24 November 2017

Yiru Fang

8

1 reference

24 November 2017

Chen Zhang

9

1 reference

24 November 2017

10 May 2013

1 reference

24 November 2017

1 reference

24 November 2017

230

1 reference

24 November 2017

1

1 reference

24 November 2017

49-55

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-013-3137-2

24 November 2017

0 references

cites work

Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Glutamate system genes associated with ventral prefrontal and thalamic volume in pediatric obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Volumetric MRI assessment of brain regions in patients with refractory obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Glutamatergic dysfunction in OCD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

The 3' untranslated region of messenger RNA: A molecular 'hotspot' for pathology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Obsessive-compulsive symptoms in clozapine-treated schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Cloned glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Linkage and association of the glutamate receptor 6 gene with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive-compulsive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

No association between EGR gene family polymorphisms and schizophrenia in the Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Treatment strategies of obsessive-compulsive disorder and panic disorder/agoraphobia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Obsessive-compulsive symptoms in schizophrenia: associated clinical features, cognitive function and medication status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

The genetics of obsessive compulsive disorder: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Interaction between genetic variants of DLGAP3 and SLC1A1 affecting the risk of atypical antipsychotics-induced obsessive-compulsive symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Association between polymorphisms in GRIK2 gene and obsessive-compulsive disorder: a family-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Comprehensive family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Clozapine-induced obsessive-compulsive symptoms in schizophrenia: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Association study of tryptophan hydroxylase-2 gene in schizophrenia and its clinical features in Chinese Han population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Association Testing of the Positional and Functional Candidate Gene SLC1A1/EAAC1 in Early-Onset Obsessive-compulsive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3137-2

Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics

21 January 2018

1 reference

12 December 2020

The prognostic significance of obsessive-compulsive symptoms in schizophrenia

1 reference

12 December 2020

Clozapine versus other atypical antipsychotics for schizophrenia

1 reference

12 December 2020

Twin studies on obsessive-compulsive disorder: a review

1 reference

12 December 2020

SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci

1 reference

12 December 2020

Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine

1 reference

12 December 2020

Quetiapine and obsessive-compulsive symptoms (OCS): case report and review of atypical antipsychotic-induced OCS

1 reference

12 December 2020

Obsessive-compulsive symptoms in schizophrenia: prevalance and clinical correlates

1 reference

12 December 2020

10.1007/S00213-013-3137-2

Identifiers

DOI

1 reference

Dimensions Publication ID

24 November 2017

0 references

1 reference